|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 325 7th Street, NW |
Address2 | Suite 400 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 66693-1005460
|
||||||||
|
6. House ID# 356240167
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Crossley Sanford |
Date | 7/19/2012 2:49:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 5, HEALTH Act (Gingrey) - IPAB repeal, medical liability reform, McCarran-Ferguson
H.R. 452, Medicare Decisions Accountability Act (Roe) - IPAB repeal, medical liability reform, McCarran-Ferguson
H.R.611 -- BEST PRACTICES Act (Rush) - data security
H.R. 1173, Fiscal Responsibility and Retirement Security Act (Boustany) - National Clearinghouse for LTC Information
H.R. 1409, Quality Health Care Coalition Act (Conyers) - antitrust exemption for physicians
H.R. 1707, Data Accountability and Trust Act (Rush) - data security
H.R. 1841, Data Accountability and Trust Act (Stearns) - data security
H.R. 2576, (Black) - eligibility for health care assistance
H.R. 2577, Secure and Fortify Electronic Data Act (Bono Mack) - data security
H.R. 2676, Small Business Health Relief Act (Schweikert) - repeal of premium tax and other ACA provisions
H.R. 5652, Sequester Replacement Reconciliation Act (Ryan) - ACA provisions, deficit reduction proposals
H.R. 5800, Health Care Price Transparency Promotion Act (Burgess) - price transparency
H.R. 5909, Comprehensive Dental Reform Act (Cummings) - expanded access to dental services
S. 1049, Small Business Health Relief Act (Kyl) - repeal of premium tax and other ACA provisions
S. 1099, HEALTH Act (Blunt) - medical liability reform
S. 1151, Personal Data Privacy and Security Act (Leahy) - privacy, data security
S. 1207, Data Security and Breach Notification Act (Pryor) - data security
S. 1408, Data Breach Notification Act (Feinstein) - data security
S. 1535, Personal Data Protection and Breach Accountability Act (Blumenthal) - data security
S. 1789, 21st Century Postal Service Act (Lieberman) -- health benefits for postal employees
S. 2111, Cyber Crime Protection Security Act (Leahy) - privacy
S. 3272, Comprehensive Dental Reform Act (Sanders) - expanded access to dental services
S. 3295, Labor, HHS, Education Appropriations Act (Harkin) - funding for HHS programs and agencies, ACA related amendments
S. 3333, Data Security and Breach Notification Act (Toomey) - data security
S. 3351, Protect Our Health Privacy Act (Franken) - privacy
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
D. Patrick |
Robertson |
|
Deputy to the Chief of Staff, Senator Rockefeller |
|
D. Patrick |
Robertson |
|
Leg. Aide & Leg. Correspondent, Senator Rockefeller |
|
Scott |
Styles |
|
Leg. Aide, State Department |
|
Scott |
Styles |
|
Chief of Staff, Rep. Pete Sessions |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.Con.Res. 112, House budget resolution (Ryan) - Medicare, Medicaid, ACA issues
H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011 (Herger)
H.R. 999, Medicare Prescription Drug Savings and Choice Act (Schakowsky) - Medicare Part D changes
H.R. 1063, Strengthening Medicare And Repaying Taxpayers Act (Murphy) - Medicare secondary payer rules
H.R. 1357, Puerto Rico Medicare Part B Equity Act (Pierluisi)
H.R. 1580, Medicare Beneficiary Preservation of Choice Act (Gonzalez) - Medicare Advantage enrollment periods
H.R. 2190, Medicare Drug Savings Act (Waxman) - rebates for dual eligibles
H.R. 2248, Medicare Prescription Drug Price Negotiation Act (Welch) - Part D price negotiation
H.R. 2770, Medicare Cost Contract Extension Act (Paulsen) - extension of Medicare cost plans
H.R. 3399, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act (Roskam/Carney)
H.R. 3519 (Towns) - exempting Medicare from sequestration
H.R. 3691, Senior Medicare Fairness Act (Paulsen) - frailty adjuster for certain MA SNPs
H.R. 4254, Medicare Advantage Program Integrity Act (Stark) - MA payment changes
H.R. 5979, Medicaid Accountability and Care Act (Cassidy) -- federal financing of state Medicaid programs
S. 31, Prescription Drug and Health Improvement Act (Franken) - Part D price negotiation
S. 44, Medicare Prescription Drug Price Negotiation Act (Klobuchar) - Part D price negotiation
S. 560, Medicare Prescription Drug Savings and Choice Act (Durbin) - Medicare Part D changes
S. 1206, Medicare Drug Savings Act (Rockefeller) - rebates for dual eligibles
S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act (Coburn/Carper)
S. 1479, Medicare Beneficiary Preservation of Choice Act (Casey) - Medicare Advantage enrollment periods
S. 1497, Medicare Cost Contract Extension Act (Klobuchar) - extension of Medicare cost plans
S. 1999, Senior Medicare Fairness Act (Klobuchar) - frailty adjuster for certain MA SNPs
S. 2196, Congressional Health Care for Seniors Act (Paul) - reforms affecting Medicare and Medigap
S. 2243, Medicare Better Health Rewards Program Act (Wyden-Portman) - incentives for wellness and prevention
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
D. Patrick |
Robertson |
|
Deputy to the Chief of Staff, Senator Rockefeller |
|
D. Patrick |
Robertson |
|
Leg. Aide & Leg. Correspondent, Senator Rockefeller |
|
Scott |
Styles |
|
Leg. Aide, State Department |
|
Scott |
Styles |
|
Chief of Staff, Rep. Pete Sessions |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R. 63, Long-Term Care Insurance Reform Act (Doggett) - LTC insurance reforms
H.R. 111, Breast Cancer Patient Protection Act (DeLauro) - minimum hospital stays for mastectomy patients
H.R. 346, Health Care Choice Act (Pearce ) - national marketplace for individual coverage
H.R.371, Health Care Choice Act (Blackburn) - national marketplace for individual coverage
H.R. 416, Health Insurance Rate Review Act (Schakowsky) - rate review
H.R. 1050, Small Business Health Fairness Act (Johnson) - association health plans
H.R. 1150, Competitive Health Insurance Reform Act (Gosar) - antitrust policy
H.R.1206, Access to Professional Health Insurance Advisors Act (Rogers) - agent commissions, medical loss ratios
H.R. 1943, Health Insurance Industry Fair Competition Act (DeFazio) - changes to McCarran-Ferguson Act
H.R. 2077, MLR Repeal Act (Price) - medical loss ratios
H.R. 2645, Medigap Medical Loss Ratio Improvement Act (Stark) - MLRs for Medigap policies
H.R. 2958, Federal Employee Short-Term Disability Insurance Act (Holmes Norton) - disability program for federal employees
H.R. 5838, Health Insurance Industry Antitrust Enforcement Act (Conyers) - changes to McCarran-Ferguson Act
S. 137, Health Insurance Rate Review Act (Feinstein) - rate review
S. 159, Confidence in Long-Term Care Insurance Act (Kohl) - LTC insurance reforms
S. 1416, Medigap Medical Loss Ratio Improvement Act (Kerry) - MLRs for Medigap policies
S. 1500, Ensure Children Have Health Care Act (Murkowski/Enzi) - enrollment period for child-only policies
S. 2068, Access to Independent Health Insurance Advisors Act (Landrieu/Isakson) - agent commissions, medical loss ratios
S. 2288, Access to Independent Health Insurance Advisors Act (Landrieu/Isakson) - agent commissions, medical loss ratios
S. 3229, Long-Term Care Insurance Consumer Right-to-Know Act (Klobuchar) -- model disclosure form for marketing long-term care insurance policies
S. 3230, Long-Term Care Integrity Act (Klobuchar) -- claims dispute resolution procedures
S. 3271, Equal Access to Medicare Options Act (Kerry) - Medigap provisions, MA enrollment provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
D. Patrick |
Robertson |
|
Deputy to the Chief of Staff, Senator Rockefeller |
|
D. Patrick |
Robertson |
|
Leg. Aide & Leg. Correspondent, Senator Rockefeller |
|
Scott |
Styles |
|
Leg. Aide, State Department |
|
Scott |
Styles |
|
Chief of Staff, Rep. Pete Sessions |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R.369, Health Savings and Affordability Act (Austria) - HSA improvements
H.R. 436, Health Care Cost Reduction Act (Paulsen) - HSA, HRA, FSA provisions, ACA provisions
H.R. 450, Restoring Assistance for Families' and Seniors' Health Expenses Act (Reichert) - repeal of HSA and FSA restrictions
H.R. 524, Restoring Consumer-driven Health Care Act (Quayle) - repeal of HSA restrictions
H.R. 605, Patients' Freedom to Choose Act (Paulsen) - repeal of HSA and FSA restrictions
H.R. 1004, Health Flexible Spending Arrangements Improvements Act (Boustany) -- distribution of unused amounts from a Health FSA
H.R. 1370, Repeal of ACA Premium Tax (Boustany)
H.R. 2010, Family and Retirement Health Investment Act (Paulsen) - HSA and FSA improvements
H.R. 2529, Restoring Access to Medication Act (Jenkins) - use of HSA funds and FSA funds to purchase OTC medications
H.R. 5842, Restoring Access to Medication Act (Jenkins) - use of HSA, HRA, and FSA funds for over-the-counter medications
H.R. 5858, Health Savings Accounts Improvements Act (Herger) - HSA provisions
H.R. 6005, Long-Term Care and Retirement Security Act (Courtney) - tax incentives for purchase of LTC insurance, consumer protections
H.R. 5651, FDA Reform Act (Upton) - pharmaceutical, medical device issues
S. 312, Patients' Freedom to Choose Act (Hutchison) - repeal of HSA and FSA restrictions
S. 1098, Family and Retirement Health Investment Act (Hatch) - HSA and FSA improvements
S. 1368, Restoring Access to Medication Act (Roberts) - use of HSA funds and FSA funds to purchase OTC medications
S. 1880, Jobs and Premium Protection Act (Barrasso) - repeal of health insurance premium tax
S. 2516, the FDA Safety and Innovation Act (Harkin) - pharmaceutical, medical device issues
S. 3187, the FDA Safety and Innovation Act (Harkin) - pharmaceutical, medical device issues
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
D. Patrick |
Robertson |
|
Deputy to the Chief of Staff, Senator Rockefeller |
|
D. Patrick |
Robertson |
|
Leg. Aide & Leg. Correspondent, Senator Rockefeller |
|
Scott |
Styles |
|
Leg. Aide, State Department |
|
Scott |
Styles |
|
Chief of Staff, Rep. Pete Sessions |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs
H.R.1946, Preserving Hometown Independent Pharmacies Act (Marino) - antitrust exemption for independent pharmacies
H.R. 3988, Generic Drug and Biosimilar User Fee Act (Murphy/Pitts/Waxman) - FDA user fee programs
H.R. 3995, Protecting Consumer Access to Generic Drugs Act (Rush) - pay-for-delay settlements
H.R. 5651, FDA Reform Act (Upton) - pharmaceutical, medical device issues
S. 27, Preserve Access to Affordable Generics Act (Kohl) - pay-for-delay settlements
S. 2193, Ensuring Safe Medical Devices for Patients (Merkley) - FDA oversight of medical devices
S. 2516, the FDA Safety and Innovation Act (Harkin) - pharmaceutical, medical device issues
S. 3187, the FDA Safety and Innovation Act (Harkin) - pharmaceutical, medical device issues
S. 2002, Online Pharmacy Safety Act (Feinstein) - establishes standards for on-line pharmacies
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
D. Patrick |
Robertson |
|
Deputy to the Chief of Staff, Senator Rockefeller |
|
D. Patrick |
Robertson |
|
Leg. Aide & Leg. Correspondent, Senator Rockefeller |
|
Scott |
Styles |
|
Leg. Aide, State Department |
|
Scott |
Styles |
|
Chief of Staff, Rep. Pete Sessions |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |